Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

NEW YORK, May 24, 2013 /PRNewswire/ -- In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today announced acceptance levels its original offer for Elan Corporation (NYSE: ELN).

Background

On 2 May 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") made an offer for the entire of the issued and to be issued share capital of Elan Corporation, plc ("Elan") (the "Original Offer"). 

On 20 May 2013, Royalty Pharma announced the terms of a revision to the Original Offer (the "Increased Offer"). The Increased Offer was made on 23 May 2013 and is an all cash offer of US$12.50 per Elan Share (including each Elan Share represented by an Elan ADS). The full terms of, and conditions to, the Increased Offer and the procedure for acceptance are set out in the revised offer document despatched by Royalty Pharma on 23 May 2013 (the "Revised Offer Document"). 

A reference in this announcement to the "Offer" means the Original Offer (including where the context so requires, any subsequent revision, variation, extension or renewal of the Original Offer, including in connection with the Increased Offer). Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Revised Offer Document.

Royalty Pharma is making this announcement in accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the US Exchange Act.

Level of Acceptances

As at 1:00 p.m. (Irish time) / 8:00 a.m. (New York City time) on 23 May 2013 (being the date the Original Offer was revised), Royalty Pharma had received valid acceptances of the Offer (which had not been withdrawn) from Elan Stockholders in respect of 67,814 Elan Shares (including Elan Shares represented by Elan ADSs). These acceptances represent, at th
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Actavis plc (NYSE: ACT ... , Chief Communications Officer, will retire from Actavis ... conjunction with Mayr,s retirement, Alex Kelly , ... Chief Communications Officer, effective immediately. Prior to joining ... President, Chief Communications Officer, Public Affairs and Investor ...
(Date:4/20/2015)... BILLERICA, Mass. , April 20, 2015 /PRNewswire/ ... tools for cell metabolism research, introduces the XFp ... a unique real-time assay on live cells that ... one-hour test measures both the mitochondrial and glycolytic ... values with metabolic activity under stressed conditions, induced ...
(Date:4/20/2015)... 2015 This report analyzes the worldwide markets for ... the following Product Segments: Sphygmomanometers (Aneroid Sphygmomanometers, & Digital Sphygmomanometers), ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided for the period ...
Breaking Medicine Technology:Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3New XFp Cell Energy Phenotype Test Determines Metabolic Potential 2New XFp Cell Energy Phenotype Test Determines Metabolic Potential 3World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28
... WIRE)--May 14, 2007 - Oculus Innovative,Sciences, Inc. ... the subject of a poster presentation at ... was held in,Glasgow, Scotland this past week., ... Antimicrobial,Solution in the Treatment of Infected Chronic ...
... Symptom Severity; New,Resources for Patients, Parents, WASHINGTON, May ... by the National Consumers League shows that American,asthma ... Four in,ten asthma sufferers understand asthma medication categories,somewhat ... the diagnosis, the less,knowledgeable adult patients tend to ...
Cached Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3New Survey Finds Troubling Data on American Asthma Sufferers 2New Survey Finds Troubling Data on American Asthma Sufferers 3New Survey Finds Troubling Data on American Asthma Sufferers 4New Survey Finds Troubling Data on American Asthma Sufferers 5New Survey Finds Troubling Data on American Asthma Sufferers 6
(Date:4/21/2015)... Timonium, Maryland (PRWEB) April 21, 2015 eSight ... who are legally blind to see and, on Tuesday, May ... (LVS of MD & VA) will host an unveiling ... Timonium, MD office. LVS of MD & VA will be ... eyewear. A limited number of individual patient demonstrations will be ...
(Date:4/21/2015)... April 21, 2015 Bulk food-grade ... 3.8 out of 5, indicating generally favorable purchasing conditions ... low barriers to entry and the fact that most ... relatively short distances,” says IBISWorld research analyst Hayden Shipp. ... country, typically serving local and regional markets.” Suppliers include ...
(Date:4/21/2015)... San Antonio, TX (PRWEB) April 21, 2015 ... reconstruction, PRMA is actively involved in various components ... basic science fields. , "Breast reconstruction ... outcomes following mastectomy. Despite recent advances, many ... order to provide patients with optimal results," says ...
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has ... prep school in Byfield, MA. Applications are being accepted ... entering grades 6-12. , The outstanding professional, college, and ... coaching. , Offensive and defensive linemen and ... the most unsung positions on the field, the the ...
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 ... solutions for biopharmaceutical development, today announced that the ... the University of Ottawa has acquired a Freeslate ... Screening Pressure Reactor (SPR) to accelerate current ... High-Throughput Experimentation Facility where they will be available to ...
Breaking Medicine News(10 mins):Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3
... report in The Journal of the American Medical Association. ... levels with a diet supplement of folic acid alone ... University of California at San Francisco and colleagues used ... cost effectiveness of lowering levels of homocystine through grains ...
... segment with its "Smoquit" (buproprion 150mg tabs) recently. The ... decade as an antidepressant, albeit at a different dose. ... ever available for the treatment of smoking problem, is ... under medical supervision and guidance. // ,Smoking ...
... compare digital mammography with the standard technique to confirm ... more accuracy. Standard film mammography has been around for ... the scope and limitations of the technology.// ,Digital ... with dense breast tissue, because it offers higher contrast. ...
... who drink in moderation – between one and seven ... than either abstainers or heavier drinkers who consume more ... ,Dr Kenneth Mukamal and colleagues at Beth Israel ... consumption among elderly patients appeared to protect against age-related ...
... a cardiac arrest and are easier to use. Nearly ... year in the United States.// Many lives could be saved ... an automated electrical defibrillator (AED), a device which delivers an ... put more AED's in public places, like shopping malls, and ...
... developing cataracts, scientists have found. A cataract is a cloudy ... eye.As the opacity thickens, it prevents light rays from passing ... sensitive tissue lining the back of the eye. It is ... who were exposed to high levels of sunlight, or solar ...
Cached Medicine News:
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Pipetman Ultra is a fully adjustable, ... display. It is the latest member of ... same characteristics: robustness, accuracy, and precision. We ... on feedback from our customers. Eight models ...
Medicine Products: